Details for New Drug Application (NDA): 206056
✉ Email this page to a colleague
NDA 206056 describes PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER, which is a drug marketed by B Braun Medical and is included in one NDA. It is available from one supplier. Additional details are available on the PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER profile page.
The generic ingredient in PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
The generic ingredient in PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 206056
| Tradename: | PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER |
| Applicant: | B Braun Medical |
| Ingredient: | piperacillin sodium; tazobactam sodium |
| Patents: | 0 |
Pharmacology for NDA: 206056
| Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 206056
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | piperacillin sodium; tazobactam sodium | POWDER;INTRAVENOUS | 206056 | NDA | B. Braun Medical Inc. | 0264-3446 | 0264-3446-11 | 24 CONTAINER in 1 CASE (0264-3446-11) / 50 mL in 1 CONTAINER |
| PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | piperacillin sodium; tazobactam sodium | POWDER;INTRAVENOUS | 206056 | NDA | B. Braun Medical Inc. | 0264-3448 | 0264-3448-11 | 24 CONTAINER in 1 CASE (0264-3448-11) / 50 mL in 1 CONTAINER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | ||||
| Approval Date: | Apr 3, 2025 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | ||||
| Approval Date: | Apr 3, 2025 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | ||||
| Approval Date: | Apr 3, 2025 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
